Literature DB >> 34653676

USP30-AS1 contributes to mitochondrial quality control in glioblastoma cells.

Ningchao Wang1, Jiao Li2, Qilei Xin3, Naihan Xu4.   

Abstract

Glioblastoma is the most serious type of brain cancer with poor prognosis. Here, using the publicly available glioma database, we identified that USP30-AS1, an antisense lncRNA locating on the opposite strand of USP30 locus, is upregulated in human gliomas, particularly in high grade glioma. High level of USP30-AS1 is correlated with poor survival in both primary and recurrent glioma patients. USP30-AS1 regulates mitochondrial homeostasis and mitophagy in glioblastoma cells. Knockdown of USP30-AS1 decreases mitochondrial protein expression and mitochondrial mass, promotes mitochondrial uncoupler-induced mitophagy. However, USP30-AS1 does not regulate USP30 expression in a cis-regulatory manner. In summary, this study proposed that USP30-AS1 may serve as a valuable prognostic marker for gliomas. USP3-AS1 is a negative regulator of mitophagy and the regulatory effect is USP30-independent. USP30-AS1 mediated repression of mitophagy may contribute to the loss of mitochondrial homeostasis and tumor development in glioma.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Glioblastoma; LncRNA; Mitochondria; Mitophagy; USP30-AS1

Mesh:

Substances:

Year:  2021        PMID: 34653676     DOI: 10.1016/j.bbrc.2021.10.006

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Construction of a four-mRNA prognostic signature with its ceRNA network in CESC.

Authors:  Lang Li; Qiusheng Guo; Gaochen Lan; Fei Liu; Wenwu Wang; Xianmei Lv
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

2.  The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response.

Authors:  Francisco J Enguita; Ana Lúcia Leitão; J Tyson McDonald; Viktorija Zaksas; Saswati Das; Diego Galeano; Deanne Taylor; Eve Syrkin Wurtele; Amanda Saravia-Butler; Stephen B Baylin; Robert Meller; D Marshall Porterfield; Douglas C Wallace; Jonathan C Schisler; Christopher E Mason; Afshin Beheshti
Journal:  Theranostics       Date:  2022-05-09       Impact factor: 11.600

3.  The Establishment and Experimental Verification of an lncRNA-Derived CD8+ T Cell Infiltration ceRNA Network in Colorectal Cancer.

Authors:  Qi Wu; Zhiyuan Zhang; Meiling Ji; Tao Yan; Yudong Jiang; Yijiao Chen; Jiang Chang; Jicheng Zhang; Dong Tang; Dexiang Zhu; Ye Wei
Journal:  Clin Med Insights Oncol       Date:  2022-04-22

4.  Amino Acid Metabolism-Related lncRNA Signature Predicts the Prognosis of Breast Cancer.

Authors:  Yin-Wei Dai; Zhi-Kai Wen; Zhi-Xuan Wu; Hao-Dong Wu; Lin-Xi Lv; Cong-Zhi Yan; Cong-Hui Liu; Zi-Qiong Wang; Chen Zheng
Journal:  Front Genet       Date:  2022-05-13       Impact factor: 4.772

5.  Necroptosis-Associated lncRNA Prognostic Model and Clustering Analysis: Prognosis Prediction and Tumor-Infiltrating Lymphocytes in Breast Cancer.

Authors:  Shigui Tao; Kunlin Tao; Xiaoyong Cai
Journal:  J Oncol       Date:  2022-04-27       Impact factor: 4.501

6.  lncRNA USP30-AS1 sponges miR-765 and modulates the progression of colon cancer.

Authors:  Chengren Li; Xu Liang; Yongguang Liu
Journal:  World J Surg Oncol       Date:  2022-03-08       Impact factor: 2.754

7.  An Immune-Related lncRNA Pairing Model for Predicting the Prognosis and Immune-Infiltrating Cell Condition in Human Ovarian Cancer.

Authors:  Xiaocui Zhang; Qing Yang
Journal:  Biomed Res Int       Date:  2022-08-16       Impact factor: 3.246

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.